Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir
- 16 May 2002
- journal article
- review article
- Published by Elsevier in Antiviral Research
- Vol. 55 (2), 209-225
- https://doi.org/10.1016/s0166-3542(02)00052-9
Abstract
No abstract availableKeywords
This publication has 105 references indexed in Scilit:
- Processing by CD26/dipeptidyl‐peptidase IV reduces the chemotactic and anti‐HIV‐1 activity of stromal‐cell‐derived factor‐1αFEBS Letters, 1998
- Quantification of latent tissue reservoirs and total body viral load in HIV-1 infectionNature, 1997
- Decay characteristics of HIV-1-infected compartments during combination therapyNature, 1997
- CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1Science, 1996
- Activity of the (R)-Enantiomers of 9-(2-Phosphonylmethoxypropyl)-Adenine and 9-(2-Phosphonylmethoxypropyl)-2,6-diaminopurine against Human Immunodeficiency Virus in Different Human Cell SystemsBiochemical and Biophysical Research Communications, 1996
- Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T CellsScience, 1995
- Correlation between Induction of Lymphocyte Apoptosis and Prostaglandin E2 Production by Macrophages Infected with HIVCellular Immunology, 1993
- Electron microscopic observation of the aggregation of membrane proteins in human erythrocyte by melittinBiochimica et Biophysica Acta (BBA) - Biomembranes, 1990
- Human red blood cells as bioreactors for the release of 2′,3′-dideoxycytidine, an inhibitor of HIV infectivityBiochemical and Biophysical Research Communications, 1989
- Oligomeric structure and the anion transport function of human erythrocyte band 3 proteinThe Journal of Membrane Biology, 1984